ALK and lymphoma: On the basis of our previous study, the aberrant expression of Sox2 in these lymphoma cells is attributed to the constitutive activation of the NPM-ALK/STAT3 axis, and inhibition of either ALK or STAT3 led to a substantial decrease in Sox2 expression [22].